Selling Securityholders Register $31.39M in Common Stock for Resale, Including Full Exit by Invenra Inc.
TWST has more than doubled off its 52-week low of $23.3.
Summary
Twist Bioscience has filed a prospectus supplement to register 632,328 shares of common stock, valued at approximately $31.39 million, for resale by selling securityholders, including a full exit by Invenra Inc., with the company receiving no proceeds.
Key Events · Financing and Capital Events · TWST
-
Significant Resale Offering
Registers 632,328 shares of common stock for resale by selling securityholders, representing approximately $31.39 million based on a recent closing price. This follows a related issuance disclosed in an 8-K on the same day.
-
No Proceeds to Company
Twist Bioscience will not receive any proceeds from the sale of these shares, indicating that the offering is solely for the benefit of the selling securityholders.
-
Major Investor Exiting Position
Invenra Inc., a significant selling securityholder, is registering all 324,558 of its shares for resale, signaling a complete exit of its registered holdings.
-
Potential Selling Pressure
The registration of a substantial block of shares for resale creates an overhang on the stock, potentially leading to increased selling pressure and price volatility.
Analysis · TWST · Life Sciences
This 424B7 prospectus supplement registers a substantial amount of common stock for resale by selling securityholders, following a related issuance disclosed in an 8-K on the same day. The company will not receive any proceeds from these sales, indicating a significant potential for selling pressure on the stock. The fact that Invenra Inc. is registering all of its previously held shares for resale, effectively exiting its position, is a particularly strong negative signal, suggesting a lack of long-term conviction from a significant holder. This event creates an overhang on the stock and could lead to price volatility as these shares enter the market.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 34.9% of the 1159 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TWST was trading at $47.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3B. The 52-week trading range was $23.30 to $51.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.